drugset / Trial / NCT02183623

The Effect of Multiple Oral Doses of BI 1356 BS on Pharmacokinetics, Safety and Tolerability of Multiple Oral Doses of Simvastatin and on the Pharmacokinetics of Its Metabolite Simvastatin Acid in Healthy Male Volunteers

NCT02183623

Phase 1 Completed 20 enrolled Boehringer Ingelheim
NaSingle-groupOpen-labelTreatment

Summary

Investigation of the multiple dose pharmacokinetics, safety and tolerability of simvastatin and simvastatin acid with and without concomitant administration of BI 1356 BS

Timeline

Start
2005-09
Primary completion
2005-10
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Linagliptin Small molecule 10 mg Oral
Subject Simvastatin Small molecule 40 mg Oral

Indications

No indication recorded.